DYNACIN^® (minocycline HCl) Tablets, USP
Dynacin^® Tablets are available in a range of strengths for adjunctive use in severe acne.
View Prescribing Information

LOPROX^® (ciclopirox)
The most prescribed branded family of antifungal products among dermatologists and podiatrists, LOPROX^® is available in shampoo, and gel.¹
View Safety Information
View Prescribing Information (Gel)
View Prescribing Information (Shampoo)
View Web site

PLEXION^® (sodium sulfacetamide 10% and sulfur 5%)
PLEXION^® Cleanser is the leading brand of sodium sulfacetamide and sulfur cleanser in detmatology. The PLEXION family also includeds PLEXION SCT, and Plexion Cleansing Cloths.
View Safety Information
View Prescribing Information
View Web site

SOLODYN^® (minocycline HCl, USP) Extended Release Tablets
Recall Information
The brand of minocycline most prescribed by dermatologists¹, SOLODYN^® tablets are indicated to treat only inflammatory lesions of non-nodular, moderate to severe acne vulgaris in patients 12 years of age and older.
View Safety Information
View Prescribing Information
View Web site

TRIAZ^® (benzoyl peroxide)
One of the leading prescription brands of topical benzoyl peroxide for acne, the TRIAZ^® family includes TRIAZ Cleanser and TRIAZ Pads, both available in multiple strengths.¹
View Safety Information
View Prescribing Information
View Web site

VANOS® (fluocinonide) 0.1% Cream
A Class I corticosteroid in a cream with ointment-like ingredients.
View Safety Information
View Prescribing Information
View Web site

ZIANA® (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel
The first and only topical acne product combining an antibiotic and a retinoid for patients 12 years of age or older.
View Patient Prescribing Information
View Full Prescribing Information
View Web site

Restylane^®
The #1 selling brand of dermal filler in the U.S. and worldwide, Restylane^® is approved to treat moderate to severe facial wrinkles and folds, such as the lines from your nose to the corners of your mouth.
View Product and Safety Information
View Web site

Perlane^®
Featuring larger particles and approved for deeper injection than Restylane^®, Perlane^® gives physicians and patients another treatment option.
View Product and Safety Information
     (Printer-friendly version)
View Frequently Asked Questions For Patients
View Web site

AMMONUL^® (sodium phenylacetate and sodium benzoate) Injection 10%/10%
AMMONUL^® is indicated as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. Ammonul is available in single-use glass vials.
View Safety Information
View Prescribing Information
View Web site

BUPHENYL^® (sodium phenylbutyrate)
BUPHENYL^® is indicated as adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS). It is indicated in all patients with neonatal-onset deficiency (complete enzymatic deficiency, presenting after the first 28 days of life). It is also indicated in patients with late-onset disease (partial enzymatic deficiency, presenting after the first month of life) who have a history of hyperammonemic encephalopathy.
View Safety Information
View Prescribing Information
View Web site